AltRx Pricing Through September 2026: What Happens After Promotion

Last reviewed: September 15, 2026 Last updated: September 15, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

AltRx advertised compounded semaglutide injection at promotional rates starting at $89 per month and compounded tirzepatide injection starting at $149 per month through a promotion ending September 5, 2026 (captured September 4, 2026 from altrx.com). Those figures were explicitly labeled as promotional. No standard, post-promotion, or refill pricing appears in AltRx's public materials captured before or immediately after that deadline. Without documented ongoing rates, we cannot calculate what long-term treatment actually costs once the promotion expires or whether monthly subscribers renew at the same price. One Trustpilot report alleged being charged for a full year despite selecting month-to-month service (captured September 4, 2026), raising a question about billing practices that the advertised "cancel anytime" policy does not resolve. If you are comparing providers for sustained use, confirm the post-promotion rate, renewal terms, and cancellation mechanics directly at checkout before committing.

AltRx promotional pricing snapshot (valid through September 5, 2026)

AltRx's website displayed the following promotional rates, captured September 4, 2026:

Source: AltRx website, captured September 4, 2026. All rates labeled as promotional, valid through September 5, 2026. Medical oversight, medication, support, and shipping included; no separate membership fee. Same price at all doses.

The central problem: no documented post-promotion pricing

The promotional grid captured from AltRx explicitly stated an end date of September 5, 2026. Our evidence sweep—before, on, and immediately after that date—found no published standard rates, no refill pricing, and no statement of what monthly subscribers would pay upon renewal. AltRx's site presented only the time-limited promotional tiers. When a provider advertises an introductory rate but does not disclose the ongoing rate, you cannot calculate true long-term cost or compare programs fairly. A monthly rate that appears competitive during a promotion may jump significantly afterward, or it may stay the same—the evidence does not tell us which.

This gap is decision-blocking if your treatment horizon is six months or longer. Weight management with GLP-1 receptor agonists typically continues for many months, and the economic difference between an $89 first month that renews at $89 versus one that renews at, for example, $189, is over $1,000 per year.

Reported billing-practice concern

One Trustpilot review, captured September 4, 2026, alleged that the reviewer was charged for a full year upfront despite selecting a month-to-month plan. A Reddit thread echoed a similar report. AltRx's promotional materials stated "cancel anytime," which ordinarily implies monthly billing with no lock-in. These are individual customer allegations—not verified facts and not necessarily representative—but they raise a question: does "cancel anytime" mean you can cancel before the next monthly charge, or does the platform's payment system sometimes process a longer commitment than the user selected? We cannot resolve the conflict from public evidence. If you choose AltRx, confirm at checkout exactly what charge will process, when, and what the cancellation mechanic is before submitting payment information.

Calculating hypothetical long-term cost (assuming promotional rates continue)

If AltRx's promotional rates were to remain in effect indefinitely—an assumption the evidence does not support—the 12-month cost would look like this (our calculation):

AltRx figures assume promotional rates continue unchanged beyond September 5, 2026, which is not documented. PlexusDx figures are standing published rates as of September 2026.

On paper, AltRx's promotional 12-month prepaid rate for semaglutide ($900 per year, or an effective $75 per month) sits $888 below PlexusDx's month-to-month rate and $888 below PlexusDx's six-month prepaid rate over the same period. For tirzepatide, AltRx's promotional 12-month prepaid ($1,500 per year, $125 per month effective) is $1,968 below PlexusDx month-to-month and $1,488 below PlexusDx six-month prepaid.

But these comparisons rest entirely on the assumption that AltRx's promotional pricing either remains available or renews at the same rate—an assumption the evidence cannot support. If the post-promotion rate is materially higher, the long-term advantage evaporates or reverses. You cannot make a sound 12-month decision with only one month's verified price.

What PlexusDx publishes

PlexusDx lists one set of rates with no promotional periods, no introductory discounts, and no undisclosed renewal jumps:

• Compounded semaglutide injection: $189/mo month-to-month, $169/mo (3-month prepaid, $507 upfront), $149/mo (6-month prepaid, $894 upfront).
• Compounded tirzepatide injection: $289/mo month-to-month, $269/mo (3-month prepaid, $807 upfront), $249/mo (6-month prepaid, $1,494 upfront).

Every price includes the provider visit, prescription review, compounded medication, and shipping. No separate membership fee, no hidden service charge. Same published rate at all doses. A licensed provider determines medical appropriateness during intake; approval is required before any charge processes.

PlexusDx works with licensed 503A compounding pharmacies. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Where AltRx may fit

If AltRx extends its promotional pricing, confirms ongoing rates at or near the advertised promotional levels, and resolves the billing-practice questions documented in customer reports, the program could offer a lower cash-pay option for patients who qualify medically and are comfortable with the unknowns. The 12-month prepaid promotional rate—if it renews at the same price—would deliver meaningful savings over both PlexusDx and many other telehealth compounding programs. Confirm the post-promotion rate, the renewal mechanic, the cancellation process, and the exact charge that will process at checkout before committing funds, especially if you select a prepaid tier.

Where PlexusDx fits

PlexusDx is built for patients who value pricing transparency and do not want to guess what next month's or next quarter's invoice will be. Our month-to-month semaglutide and tirzepatide injection rates sit higher than AltRx's documented promotional rates, but they are stable, published, and not subject to post-promotion revision. You know the cost on day 1 and on day 180. If you prefer prepayment, our six-month tiers lower the effective monthly rate without requiring a full-year commitment. A 60-second intake starts the process; a licensed provider reviews your history and determines fit before any payment processes.

Methodology and freshness

This analysis uses AltRx promotional pricing captured from altrx.com on September 4, 2026, one day before the advertised promotion end date of September 5, 2026. We conducted additional evidence sweeps immediately after that date and found no published standard or post-promotion rates. The Trustpilot review alleging unexpected annual billing was captured September 4, 2026, from trustpilot.com. PlexusDx rates are standing published figures as of September 2026. The 12-month cost projections labeled "our calculation" are arithmetic extensions of the per-month or prepaid rates and assume no rate changes, which for AltRx is an unsupported assumption. We do not apply discount arithmetic or publish offers. Every price figure carries its source and capture date. Where the evidence conflicts or leaves a question unresolved, we state the conflict plainly and recommend direct confirmation.

Frequently Asked Questions

Did AltRx's promotional pricing continue after September 5, 2026?

Our evidence captured promotional rates valid through September 5, 2026, but no post-promotion or standard rates appeared in subsequent sweeps of public materials. Confirm current pricing directly with AltRx before assuming the promotional rates remain available.

How much does AltRx charge per month after the promotion ends?

No standard, ongoing, or refill rate is documented in the evidence. The promotional grid was the only pricing published during our capture window. You must confirm the post-promotion rate at checkout or by contacting AltRx directly.

Can I cancel AltRx month-to-month service without penalty?

AltRx advertised "cancel anytime," but one Trustpilot report alleged being charged for a full year despite selecting monthly service. The conflict is unresolved in public evidence. Confirm the cancellation mechanic and what charge will process before submitting payment.

How does PlexusDx pricing compare over 12 months?

PlexusDx month-to-month semaglutide costs $2,268 per year; six-month prepaid semaglutide costs $1,788 per year. Tirzepatide month-to-month costs $3,468 per year; six-month prepaid costs $2,988 per year. These are standing published rates with no promotional windows or undisclosed renewal changes.

Are AltRx's compounded GLP-1 medications FDA-approved?

No. Compounded semaglutide and tirzepatide are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for each patient.

Sources

• AltRx promotional pricing grid, altrx.com, accessed September 4, 2026
• AltRx promotional terms and inclusions, altrx.com, accessed September 4, 2026
• Trustpilot review of AltRx alleging annual prebilling, trustpilot.com, accessed September 4, 2026
• PlexusDx published GLP-1 pricing, plexusdx.com, accessed September 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.